The FDA under President Joe Biden has the opportunity to improve the availability of Covid-19
testing. Hyman, Phelps & McNamara P.C. attorneys say the FDA can start by eliminating needless
hurdles in the regulatory approval process, providing greater clarity, and applying criteria
consistently.
Related Professionals
- Jeffrey N. Gibbs
Director - Gail H. Javitt
Director